跳至主要内容
临床试验/ACTRN12609000271202
ACTRN12609000271202招募中4 期

International Study to Predict Optimised Treatment response to short-acting methylphenidate in children and adolescents diagnosed with Attention Deficit/Hyperactivity Disorder (ADHD) as compared to matched healthy controls.

Brain Resource Pty Ltd0 个研究点目标入组 1,344 人开始时间: 2009年5月15日最近更新:
适应症

试验速览

阶段
4 期
状态
招募中
发起方
入组人数
1,344

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Non-randomised trial
主要目的
Educational / counselling / training
盲法
Open (masking not used)

入排标准

年龄范围
6 Years 至 17 Years(—)
性别
All

入选标准

  • Meet Diagnostic and Statistical Manual of Mental Disorders (DSM) IV criteria for primary diagnosis of ADHD, have an Attention Deficit / Hyperactivity Disorder Rating Scale (ADHD-RS IV) score > 6 for inattention and/or hyperactivity-impulsivity, subject is a candidate for methylphenidate, and is stimulant naive or stimulant free. Fluent and literate in English or Dutch.

排除标准

  • Prior or recent use of methylphenidate of other stimulant medication. History of brain injury/blow resulting in loss of consciousness. Severe impediment to vision, hearing and/or hand movement which may interfere with their ability to complete the protocol required tests.

研究者

发起方
Brain Resource Pty Ltd

相似试验